Affective self-report during the intracarotid sodium amobarbital test: group differences.
Emotional reactions are sometimes observed during the intracarotid sodium amobarbital test. For instance, euphoric/indifference reactions can be seen during right hemisphere inactivation and catastrophic reactions may accompany left hemisphere inactivation. Less dramatic changes can also be detected in affective self-report during left and right hemisphere amobarbital tests, with more negative affect reported during left hemisphere inactivation and either neutral or mildly positive affective states reported during right hemisphere inactivation. The current study not only replicated this effect, but in addition, found significant group differences. The first group (right way) showed a pattern of affective self-report during left and right amobarbital tests entirely consistent with prior findings, while a second group (wrong way) showed results that behaved in a diametrically opposite fashion. A third group (no change) showed little, if any, difference in affective self-report during left and right amobarbital tests. The major factor distinguishing the wrong way group from the other two appeared to be an asymmetrical distribution of left and right temporal lobe lesions in the former group. In contrast, the factor differentiating the right way group from the no change group appeared to be the relative degree of left hemisphere inactivation during the left hemisphere amobarbital test. The results are discussed not only in terms of their impact on theories of cerebral lateralization for emotion, but also in terms of methodological issues in this field.
Ahern
G L
GL
Behavioral Neuroscience and Alzheimer's Clinic, University of Arizona Health Sciences Center, Tucson 85724, USA. gahern@u.arizona.edu
Herring
A M
AM
Labiner
D M
DM
Weinand
M E
ME
Hutzler
R
R
D000293:Adolescent; D000328:Adult; D000339:Affect / Q000187:drug effects*; D000368:Aged; D000654:Amobarbital / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D001921:Brain / Q000187:drug effects* / Q000378:metabolism*; D002339:Carotid Arteries; D004569:Electroencephalography; D005260:Female; D007839:Functional Laterality / Q000187:drug effects / Q000502:physiology; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D007269:Injections, Intra-Arterial; D008297:Male; D008875:Middle Aged; D012647:Self-Assessment
D006993:Hypnotics and Sedatives; D000654:Amobarbital